Valuation: Photocure ASA

Market Cap 1.43B 150M 131M 122M 112M 211M 14.35B 214M 1.43B 563M 7.15B 565M 552M 23.96B P/E 2026 *
21.7x
P/E 2027 * 40.1x
Enterprise Value 1.22B 129M 112M 104M 95.57M 180M 12.28B 183M 1.23B 482M 6.11B 483M 473M 20.5B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.87x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.56%
1 week-5.53%
1 month-10.62%
3 months-19.45%
6 months-23.30%
Current year-25.77%
1 week 52.8
Extreme 52.8
57.8
1 month 52.8
Extreme 52.8
60.3
Current year 52.8
Extreme 52.8
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
2/4/25 BuyCompany 11,355 0.0419%
2/4/25 BuyCompany 8,997 0.0332%
31/3/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%-5.53%-18.84%+6.64% 150M
-0.53%-3.95%+55.23%+152.74% 1,030B
+0.21%-2.68%+55.61%+53.02% 617B
-2.51%-3.25%+32.76%+67.76% 455B
+0.06%-0.42%+37.53%+30.67% 350B
-0.14%-0.24%+34.41%+39.01% 299B
-0.69%-0.30%+11.55%+12.93% 265B
-7.37%-4.40%-2.54%-43.87% 225B
-0.64%+2.43%+30.52%+64.49% 209B
-0.82%+0.70%+15.96%+71.01% 163B
Average -1.30%+0.85%+25.22%+45.44% 361.28B
Weighted average by Cap. -1.02%-0.11%+39.01%+72.47%

Financials

2026 *2027 *
Net sales 664M 70.02M 60.87M 56.66M 52.02M 98.23M 6.68B 99.75M 668M 262M 3.33B 263M 257M 11.16B 673M 70.97M 61.69M 57.42M 52.72M 99.56M 6.77B 101M 677M 266M 3.37B 267M 261M 11.31B
Net income 65M 6.85M 5.96M 5.54M 5.09M 9.61M 654M 9.76M 65.34M 25.64M 326M 25.73M 25.16M 1.09B 35.67M 3.76M 3.27M 3.04M 2.79M 5.27M 359M 5.36M 35.85M 14.07M 179M 14.12M 13.81M 599M
Net Debt -206M -21.71M -18.87M -17.57M -16.13M -30.46M -2.07B -30.93M -207M -81.27M -1.03B -81.54M -79.75M -3.46B -169M -17.81M -15.48M -14.41M -13.23M -24.99M -1.7B -25.38M -170M -66.68M -847M -66.9M -65.43M -2.84B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
31/07/26 NOK 53.00 -0.56% 52,923
30/07/26 NOK 53.30 -1.48% 100,090
29/07/26 NOK 54.10 -4.75% 138,087
28/07/26 NOK 56.80 -0.18% 21,717
27/07/26 NOK 56.90 +1.43% 26,376
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
53.00NOK
Average target price
82.33NOK
Spread / Average Target
+55.35%

Quarterly revenue - Rate of surprise